VITASPRING BIOMEDICAL CO., LTD. (VSBC) Gross margin 2018–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) gross margin by fiscal year — reported gross profit divided by reported revenue.
36.8%FY2022 · since FY2018: 69.9% → 36.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 36.8% | -8.4 pp |
| FY2021 | 45.2% | +34.0 pp |
| FY2020 | 11.2% | -68.7 pp |
| FY2019 | 79.8% | +10.0 pp |
| FY2018 | 69.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Operating incomeVSBC Operating marginVSBC Operating cash flowVSBC Free cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →